AML therapy in the elderly: a time for a change

Expert Opin Drug Saf. 2016 Jul;15(7):891-2. doi: 10.1080/14740338.2016.1176139. Epub 2016 Apr 18.
No abstract available

Keywords: Acute myeloid leukemia; biomarker; elderly; fitness status; frailty.

MeSH terms

  • Age Factors
  • Aged
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / epidemiology
  • Leukemia, Myeloid, Acute / pathology
  • Survival

Substances

  • Antineoplastic Agents